| # | Title | Journal | Year | Citations |
|---|
| 1 | Human exhaled air analytics: biomarkers of diseases | Biomedical Chromatography | 2007 | 629 |
| 2 | Dried blood spot sampling in combination with LC‐MS/MS for quantitative analysis of small molecules | Biomedical Chromatography | 2010 | 518 |
| 3 | Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography | Biomedical Chromatography | 2006 | 397 |
| 4 | High-throughput quantitative bioanalysis by LC/MS/MS | Biomedical Chromatography | 2000 | 340 |
| 5 | Rapid screening and identification of α‐glucosidase inhibitors from mulberry leaves using enzyme‐immobilized magnetic beads coupled with HPLC/MS and NMR | Biomedical Chromatography | 2013 | 303 |
| 6 | Recent advances in sample preparation techniques for effective bioanalytical methods | Biomedical Chromatography | 2011 | 283 |
| 7 | Determination of bisphenol A in human breast milk by HPLC with column-switching andfluorescence detection | Biomedical Chromatography | 2004 | 235 |
| 8 | A review of chromatographic methods for the assessment of phospholipids in biological samples | Biomedical Chromatography | 2006 | 233 |
| 9 | Measurement of bisphenol A and bisphenol B levels in human blood sera from healthy and endometriotic women | Biomedical Chromatography | 2009 | 195 |
| 10 | An HPLC method for the quantification of sterols in edible seaweeds | Biomedical Chromatography | 2004 | 181 |
| 11 | Systematic LC‐MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought‐out chromatography | Biomedical Chromatography | 2010 | 179 |
| 12 | Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography–tandem mass spectrometry | Biomedical Chromatography | 2007 | 175 |
| 13 | High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin | Biomedical Chromatography | 2007 | 170 |
| 14 | The role of alternative specimens in toxicological analysis | Biomedical Chromatography | 2008 | 163 |
| 15 | Fluorogenic and fluorescent labeling reagents with a benzofurazan skeleton | Biomedical Chromatography | 2001 | 157 |
| 16 | Analysis of exhaled breath from smokers, passive smokers and non‐smokers by solid‐phase microextraction gas chromatography/mass spectrometry | Biomedical Chromatography | 2009 | 157 |
| 17 | Determination of pterostilbene in rat plasma by a simple HPLC‐UV method and its application in pre‐clinical pharmacokinetic study | Biomedical Chromatography | 2009 | 157 |
| 18 | Mass spectrometry‐based metabolomics: applications to biomarker and metabolic pathway research | Biomedical Chromatography | 2016 | 153 |
| 19 | Irinotecan and its active metabolite, SN‐38: review of bioanalytical methods and recent update from clinical pharmacology perspectives | Biomedical Chromatography | 2010 | 139 |
| 20 | Derivatization reagents in liquid chromatography/electrospray ionization tandem mass spectrometry | Biomedical Chromatography | 2011 | 136 |
| 21 | Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer | Biomedical Chromatography | 2012 | 133 |
| 22 | Analysis of antioxidant compounds in sweet orange peel by HPLC-diode array detection-electrospray ionization mass spectrometry | Biomedical Chromatography | 2005 | 132 |
| 23 | An HPLC assay of hydroxyl radicals by the hydroxylation reaction of terephthalic acid | Biomedical Chromatography | 2004 | 117 |
| 24 | Strategies in quantitative LC‐MS/MS analysis of unstable small molecules in biological matrices | Biomedical Chromatography | 2011 | 117 |
| 25 | GC-MS analysis of penta- and tetra-cyclic triterpenes from resins ofPistacia species. Part I.Pistacia lentiscus var. Chia | Biomedical Chromatography | 2005 | 116 |
| 26 | Salting‐out assisted liquid/liquid extraction with acetonitrile: a new high throughput sample preparation technique for good laboratory practice bioanalysis using liquid chromatography–mass spectrometry | Biomedical Chromatography | 2009 | 116 |
| 27 | Determination of Δ1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography-mass spectrometry | Biomedical Chromatography | 1989 | 113 |
| 28 | Direct enantiomeric separations by high performance liquid chromatography using cyclodextrins | Biomedical Chromatography | 1997 | 106 |
| 29 | Applications of hyphenated LC-MS techniques in pharmaceutical analysis | Biomedical Chromatography | 2000 | 105 |
| 30 | Enantioseparation of some clinically used drugs by HPLC using cellulose Tris (3,5-dichlorophenylcarbamate) chiral stationary phase | Biomedical Chromatography | 2003 | 105 |
| 31 | Determination of bisphenol A in rat brain by microdialysis and column switching high-performance liquid chromatography with fluorescence detection | Biomedical Chromatography | 2002 | 104 |
| 32 | Derivatization chemistries for determination of serotonin, norepinephrine and dopamine in brain microdialysis samples by liquid chromatography with fluorescence detection | Biomedical Chromatography | 2006 | 104 |
| 33 | Extraction and analysis of colourful eggshell pigments using HPLC and HPLC/electrospray ionization tandem mass spectrometry | Biomedical Chromatography | 2009 | 99 |
| 34 | Determination of amino acid enantiomers in human urine and blood serum by gas chromatography-mass spectrometry | Biomedical Chromatography | 2001 | 98 |
| 35 | Automated precolumn derivatization system for analyzing physiological amino acids by liquid chromatography/mass spectrometry | Biomedical Chromatography | 2010 | 95 |
| 36 | Purification of carbon-11 PET radiotracers from unlabeled precursors by preparative HPLC and SPE | Biomedical Chromatography | 2005 | 91 |
| 37 | Analysis of five HMG-CoA reductase inhibitors— atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis andin vitro metabolism studies | Biomedical Chromatography | 2006 | 91 |
| 38 | Development and validation of a rapid reversed-phase HPLC method for the determination of insulin from nanoparticulate systems | Biomedical Chromatography | 2006 | 90 |
| 39 | Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry | Biomedical Chromatography | 2013 | 89 |
| 40 | Simultaneous determination of creatine, uric ccid, creatinine and hippuric acid in urine by high performance liquid chromatography | Biomedical Chromatography | 1998 | 88 |
| 41 | The role of salivary peptides in dental caries | Biomedical Chromatography | 2005 | 87 |
| 42 | Comprehensive multi-dimensional liquid chromatographic separation in biomedical and pharmaceutical analysis: a review | Biomedical Chromatography | 2006 | 86 |
| 43 | A universal surrogate peptide to enable LC‐MS/MS bioanalysis of a diversity of human monoclonal antibody and human Fc‐fusion protein drug candidates in pre‐clinical animal studies | Biomedical Chromatography | 2012 | 86 |
| 44 | Capillary electrophoresis for the analysis of glycosaminoglycans and glycosaminoglycan-derived oligosaccharides | Biomedical Chromatography | 2002 | 85 |
| 45 | Simultaneous determination ofD- andL-serine in rat brain microdialysis sample using a column-switching HPLC with ?uorimetric detection | Biomedical Chromatography | 2004 | 85 |
| 46 | A rapid and simple HPLC method for the determination of curcumin in rat plasma: assay development, validation and application to a pharmacokinetic study of curcumin liposome | Biomedical Chromatography | 2009 | 85 |
| 47 | Determination of Ibuprofen in human plasma by high-performance liquid chromatography: validation and application in pharmacokinetic study | Biomedical Chromatography | 2000 | 84 |
| 48 | Determination of dopamine, serotonin, and their metabolites in pediatric cerebrospinal fluid by isocratic high performance liquid chromatography coupled with electrochemical detection | Biomedical Chromatography | 2010 | 84 |
| 49 | Occurrence ofD-aspartic acid in rat brain pineal gland | Biomedical Chromatography | 1995 | 82 |
| 50 | In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios | Biomedical Chromatography | 2007 | 82 |
